Non-Coding RNAs: Master Regulators of Inflammasomes in Inflammatory Diseases

References

• Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet. 2006;15(No suppl_1):R17–R29. doi:10.1093/hmg/ddl046
   PubMedGoogle Scholar
• Marques-Rocha JL, Samblas M, Milagro FI, Bressan J, Martínez JA, Marti A. Noncoding RNAs, cytokines, and inflammation-related diseases. FASEB J. 2015;29(9):3595–3611. doi:10.1096/fj.14-260323
   PubMed Web of Science ®Google Scholar
• Lin CC, Shen YR, Chang CC, et al. Terminal uridyltransferase 7 regulates TLR4-triggered inflammation by controlling Regnase-1 mRNA uridylation and degradation. Nat Commun. 2021;12(1):3878. doi:10.1038/s41467-021-24177-7
   PubMed Web of Science ®Google Scholar
• Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):3328. doi:10.3390/ijms20133328
   PubMed Web of Science ®Google Scholar
• Menon MP, Hua KF. The long non-coding RNAs: paramount regulators of the NLRP3 inflammasome. Front Immunol. 2020;11:569524. doi:10.3389/fimmu.2020.569524
   PubMed Web of Science ®Google Scholar
• Eisenbarth SC, Flavell RA. Innate instruction of adaptive immunity revisited: the inflammasome. EMBO Mol Med. 2009;1(2):92–98. doi:10.1002/emmm.200900014
   PubMed Web of Science ®Google Scholar
• Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477–489. doi:10.1038/s41577-019-0165-0
   PubMed Web of Science ®Google Scholar
• Bauernfeind F, Rieger A, Schildberg FA, Knolle PA, Schmid-Burgk JL, Hornung V. NLRP3 inflammasome activity is negatively controlled by miR-223. J Immunol 2012;189(8):4175–4181. doi:10.4049/jimmunol.1201516
   PubMed Web of Science ®Google Scholar
• Haneklaus M, Gerlic M, Kurowska-Stolarska M, et al. Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production. J Immunol. 2012;189(8):3795–3799. doi:10.4049/jimmunol.1200312
   PubMed Web of Science ®Google Scholar
• Zhang P, Cao L, Zhou R, Yang X, Wu M. The lncRNA Neat1 promotes activation of inflammasomes in macrophages. Nat Commun. 2019;10(1):1495. doi:10.1038/s41467-019-09482-6
   PubMed Web of Science ®Google Scholar
• Lian C, Sun J, Guan W, et al. Circular RNA circHIPK3 activates macrophage NLRP3 inflammasome and TLR4 pathway in gouty arthritis via sponging miR-561 and miR-192. Inflammation. 2021. doi:10.1007/s10753-021-01483-2
   PubMed Web of Science ®Google Scholar
• Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in oncology. Cell. 2019;179(5):1033–1055. doi:10.1016/j.cell.2019.10.017
   PubMed Web of Science ®Google Scholar
• Cai Y, Yu X, Hu S, Yu J. A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics. 2009;7(4):147–154. doi:10.1016/s1672-0229(08)60044-3
   PubMedGoogle Scholar
• Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202–1207. doi:10.1016/j.jaci.2017.08.034
   PubMed Web of Science ®Google Scholar
• Barwari T, Joshi A, Mayr M. MicroRNAs in cardiovascular disease. J Am Coll Cardiol. 2016;68(23):2577–2584. doi:10.1016/j.jacc.2016.09.945
   PubMed Web of Science ®Google Scholar
• Sun Z, Shi K, Yang S, et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer. 2018;17(1):147. doi:10.1186/s12943-018-0897-7
   PubMed Web of Science ®Google Scholar
• van den Berg MMJ, Krauskopf J, Ramaekers JG, Kleinjans JCS, Prickaerts J, Briedé JJ. Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. Prog Neurobiol. 2020;185:101732. doi:10.1016/j.pneurobio.2019.101732
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–222. doi:10.1038/nrd.2016.246
   PubMed Web of Science ®Google Scholar
• Zhang D, Lee H, Wang X, et al. A potential role of microvesicle-containing miR-223/142 in lung inflammation. Thorax. 2019;74(9):865–874. doi:10.1136/thoraxjnl-2018-212994
   PubMed Web of Science ®Google Scholar
• Shikano S, Gon Y, Maruoka S, et al. Increased extracellular vesicle miRNA-466 family in the bronchoalveolar lavage fluid as a precipitating factor of ARDS. BMC Pulm Med. 2019;19(1):110. doi:10.1186/s12890-019-0876-9
   PubMedGoogle Scholar
• Li J, Xue J, Wang D, et al. Regulation of gasdermin D by miR-379-5p is involved in arsenite-induced activation of hepatic stellate cells and in fibrosis via secretion of IL-1β from human hepatic cells. Metallomics. 2019;11(2):483–495. doi:10.1039/c8mt00321a
   PubMed Web of Science ®Google Scholar
• Zhang QB, Qing YF, Yin CC, et al. Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome. Arthritis Res Ther. 2018;20(1):45. doi:10.1186/s13075-018-1546-7
   PubMedGoogle Scholar
• Zhou L, Li P, Zhang M, et al. Carbon black nanoparticles induce pulmonary fibrosis through NLRP3 inflammasome pathway modulated by miR-96 targeted FOXO3a. Chemosphere. 2020;241:125075. doi:10.1016/j.chemosphere.2019.125075
   PubMed Web of Science ®Google Scholar
• Xie Q, Wei M, Zhang B, et al. MicroRNA‑33 regulates the NLRP3 inflammasome signaling pathway in macrophages. Mol Med Rep. 2018;17(2):3318–3327. doi:10.3892/mmr.2017.8224
   PubMed Web of Science ®Google Scholar
• Liu Y, Lou G, Li A, et al. AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3 inflammasome activation in macrophages. EBioMedicine. 2018;36:140–150. doi:10.1016/j.ebiom.2018.08.054
   PubMed Web of Science ®Google Scholar
• Li XF, Shen WW, Sun YY, et al. MicroRNA-20a negatively regulates expression of NLRP3-inflammasome by targeting TXNIP in adjuvant-induced arthritis fibroblast-like synoviocytes. Joint Bone Spine. 2016;83(6):695–700. doi:10.1016/j.jbspin.2015.10.007
   PubMed Web of Science ®Google Scholar
• Heo MJ, Kim TH, You JS, Blaya D, Sancho-Bru P, Kim SG. Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression. Gut. 2019;68(4):708–720. doi:10.1136/gutjnl-2017-315123
   PubMed Web of Science ®Google Scholar
• Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393–407. doi:10.1016/j.cell.2018.01.011
   PubMed Web of Science ®Google Scholar
• Kapranov P, Cheng J, Dike S, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 2007;316(5830):1484–1488. doi:10.1126/science.1138341
   PubMed Web of Science ®Google Scholar
• Yang Z, Jiang S, Shang J, et al. LncRNA: shedding light on mechanisms and opportunities in fibrosis and aging. Ageing Res Rev. 2019;52:17–31. doi:10.1016/j.arr.2019.04.001
   PubMed Web of Science ®Google Scholar
• Brocker CN, Kim D, Melia T, et al. Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to PPARA agonism and fasting. Nat Commun. 2020;11(1):5847. doi:10.1038/s41467-020-19554-7
   PubMed Web of Science ®Google Scholar
• Huang JZ, Chen M, Chen D, et al. A peptide encoded by a putative lncRNA HOXB-AS3 suppresses colon cancer growth. Mol Cell. 2017;68(1):171–84.e6. doi:10.1016/j.molcel.2017.09.015
   PubMed Web of Science ®Google Scholar
• Bhatta A, Atianand M, Jiang Z, Crabtree J, Blin J, Fitzgerald KA. A mitochondrial micropeptide is required for activation of the Nlrp3 inflammasome. J Immunol 2020;204(2):428–437. doi:10.4049/jimmunol.1900791
   PubMed Web of Science ®Google Scholar
• Sun M, Nie F, Wang Y, et al. LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1. Cancer Res. 2016;76(21):6299–6310. doi:10.1158/0008-5472.Can-16-0356
   PubMed Web of Science ®Google Scholar
• Wu H, Qiao F, Zhao Y, et al. Downregulation of long non-coding RNA FALEC inhibits gastric cancer cell migration and invasion through impairing ECM1 expression by exerting its enhancer-like function. Front Genet. 2019;10:255. doi:10.3389/fgene.2019.00255
   PubMed Web of Science ®Google Scholar
• Lin Y, Wang S, Gao L, et al. Oscillating lncRNA Platr4 regulates NLRP3 inflammasome to ameliorate nonalcoholic steatohepatitis in mice. Theranostics. 2021;11(1):426–444. doi:10.7150/thno.50281
   PubMed Web of Science ®Google Scholar
• Wang S, Lin Y, Li F, et al. An NF-κB-driven lncRNA orchestrates colitis and circadian clock. Sci Adv. 2020;6(42):eabb5202. doi:10.1126/sciadv.abb5202
   PubMed Web of Science ®Google Scholar
• Cai LJ, Tu L, Huang XM, et al. LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson’s disease. Mol Brain. 2020;13(1):130. doi:10.1186/s13041-020-00656-8
   PubMed Web of Science ®Google Scholar
• Pefanis E, Wang J, Rothschild G, et al. RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity. Cell. 2015;161(4):774–789. doi:10.1016/j.cell.2015.04.034
   PubMed Web of Science ®Google Scholar
• Huang Z, Du G, Huang X, et al. The enhancer RNA lnc-SLC4A1-1 epigenetically regulates unexplained recurrent pregnancy loss (URPL) by activating CXCL8 and NF-kB pathway. EBioMedicine. 2018;38:162–170. doi:10.1016/j.ebiom.2018.11.015
   PubMed Web of Science ®Google Scholar
• Ounzain S, Pedrazzini T. The promise of enhancer-associated long noncoding RNAs in cardiac regeneration. Trends Cardiovasc Med. 2015;25(7):592–602. doi:10.1016/j.tcm.2015.01.014
   PubMed Web of Science ®Google Scholar
• Yap K, Mukhina S, Zhang G, et al. Repeat-enriched RNA assembles a nuclear compartment to control alternative splicing and promote cell survival. Mol Cell. 2018;72(3):525–40.e13. doi:10.1016/j.molcel.2018.08.041
   PubMed Web of Science ®Google Scholar
• Yan B, Yao J, Liu JY, et al. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res. 2015;116(7):1143–1156. doi:10.1161/circresaha.116.305510
   PubMed Web of Science ®Google Scholar
• Chi K, Geng X, Liu C, et al. LncRNA-HOTAIR promotes endothelial cell pyroptosis by regulating the miR-22/NLRP3 axis in hyperuricaemia. J Cell Mol Med. 2021;25:8504–8521. doi:10.1111/jcmm.16812
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li T, Chen Z, Huang J, Qin Z, Li L. Overexpression of lncRNA TUG1 alleviates NLRP3 inflammasome-mediated cardiomyocyte pyroptosis through targeting the miR-186-5p/XIAP axis in coronary microembolization-induced myocardial damage. Front Immunol. 2021;12:637598. doi:10.3389/fimmu.2021.637598
   PubMed Web of Science ®Google Scholar
• Wang C, Yang Y, Zhang G, et al. Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis. Proc Natl Acad Sci U S A. 2019;116(29):14620–14629. doi:10.1073/pnas.1903432116
   PubMed Web of Science ®Google Scholar
• Dimartino D, Colantoni A, Ballarino M, et al. The long non-coding RNA lnc-31 interacts with Rock1 mRNA and mediates its YB-1-dependent translation. Cell Rep. 2018;23(3):733–740. doi:10.1016/j.celrep.2018.03.101
   PubMed Web of Science ®Google Scholar
• Xue Z, Zhang Z, Liu H, et al. lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation. Cell Death Differ. 2019;26(1):130–145. doi:10.1038/s41418-018-0105-8
   PubMed Web of Science ®Google Scholar
• Li H, Xu JD, Fang XH, et al. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4. Cardiovasc Res. 2020;116(7):1323–1334. doi:10.1093/cvr/cvz215
   PubMed Web of Science ®Google Scholar
• Su Y, Lv X, Yin W, et al. CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression. Aging. 2019;11(19):8183–8203. doi:10.18632/aging.102312
   PubMedGoogle Scholar
• Bian Y, Pang P, Li X, et al. CircHelz activates NLRP3 inflammasome to promote myocardial injury by sponging miR-133a-3p in mouse ischemic heart. J Mol Cell Cardiol. 2021;158:128–139. doi:10.1016/j.yjmcc.2021.05.010
   PubMed Web of Science ®Google Scholar
• Yan B, Zhang Y, Liang C, et al. Stem cell-derived exosomes prevent pyroptosis and repair ischemic muscle injury through a novel exosome/circHIPK3/ FOXO3a pathway. Theranostics. 2020;10(15):6728–6742. doi:10.7150/thno.42259
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang T, Feng R, Huang H, Xia T, Sun C. circARF3 alleviates mitophagy-mediated inflammation by targeting miR-103/TRAF3 in mouse adipose tissue. Mol Ther Nucleic Acids. 2019;14:192–203. doi:10.1016/j.omtn.2018.11.014
   PubMedGoogle Scholar
• Yang F, Hu A, Li D, et al. Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation. Mol Cancer. 2019;18(1):158. doi:10.1186/s12943-019-1094-z
   PubMed Web of Science ®Google Scholar
• Barbagallo D, Caponnetto A, Cirnigliaro M, et al. CircSMARCA5 inhibits migration of glioblastoma multiforme cells by regulating a molecular axis involving splicing factors SRSF1/SRSF3/PTB. Int J Mol Sci. 2018;19(2):480. doi:10.3390/ijms19020480
   PubMed Web of Science ®Google Scholar
• Sun YM, Wang WT, Zeng ZC, et al. circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression. Blood. 2019;134(18):1533–1546. doi:10.1182/blood.2019000802
   PubMed Web of Science ®Google Scholar
• Du WW, Yang W, Liu E, Yang Z, Dhaliwal P, Yang BB. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res. 2016;44(6):2846–2858. doi:10.1093/nar/gkw027
   PubMed Web of Science ®Google Scholar
• Legnini I, Di Timoteo G, Rossi F, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol Cell. 2017;66(1):22–37.e9. doi:10.1016/j.molcel.2017.02.017
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu X, Shi H, et al. NLRP3 inflammasome, an immune-inflammatory target in pathogenesis and treatment of cardiovascular diseases. Clin Transl Med. 2020;10(1):91–106. doi:10.1002/ctm2.13
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Rocheteau P, Chatre L, Briand D, et al. Sepsis induces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy. Nat Commun. 2015;6:10145. doi:10.1038/ncomms10145
   PubMed Web of Science ®Google Scholar
• Huang M, Cai S, Su J. The pathogenesis of sepsis and potential therapeutic targets. Int J Mol Sci. 2019;20(21):5376. doi:10.3390/ijms20215376
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li X, Grailer JJ, et al. Melatonin alleviates acute lung injury through inhibiting the NLRP3 inflammasome. J Pineal Res. 2016;60(4):405–414. doi:10.1111/jpi.12322
   PubMed Web of Science ®Google Scholar
• Zhan C, Lin G, Huang Y, Wang Z, Zeng F, Wu S. A dopamine-precursor-based nanoprodrug for in-situ drug release and treatment of acute liver failure by inhibiting NLRP3 inflammasome and facilitating liver regeneration. Biomaterials. 2021;268:120573. doi:10.1016/j.biomaterials.2020.120573
   PubMed Web of Science ®Google Scholar
• Lin Q, Li S, Jiang N, et al. PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation. Redox Biol. 2019;26:101254. doi:10.1016/j.redox.2019.101254
   PubMed Web of Science ®Google Scholar
• Li N, Zhou H, Wu H, et al. STING-IRF3 contributes to lipopolysaccharide-induced cardiac dysfunction, inflammation, apoptosis and pyroptosis by activating NLRP3. Redox Biol. 2019;24:101215. doi:10.1016/j.redox.2019.101215
   PubMed Web of Science ®Google Scholar
• Lou J, Wang Y, Zhang Z, Qiu W. MiR-20b inhibits mycobacterium tuberculosis induced inflammation in the lung of mice through targeting NLRP3. Exp Cell Res. 2017;358(2):120–128. doi:10.1016/j.yexcr.2017.06.007
   PubMed Web of Science ®Google Scholar
• Long FQ, Kou CX, Li K, Wu J, Wang QQ. MiR-223-3p inhibits rTp17-induced inflammasome activation and pyroptosis by targeting NLRP3. J Cell Mol Med. 2020;24(24):14405–14414. doi:10.1111/jcmm.16061
   PubMed Web of Science ®Google Scholar
• He Y, Hara H, Núñez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016;41(12):1012–1021. doi:10.1016/j.tibs.2016.09.002
   PubMed Web of Science ®Google Scholar
• Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009;27:229–265. doi:10.1146/annurev.immunol.021908.132715
   PubMed Web of Science ®Google Scholar
• Xue Z, Xi Q, Liu H, et al. miR-21 promotes NLRP3 inflammasome activation to mediate pyroptosis and endotoxic shock. Cell Death Dis. 2019;10(6):461. doi:10.1038/s41419-019-1713-z
   PubMedGoogle Scholar
• Lee H, Groot M, Pinilla-Vera M, Fredenburgh LE, Jin Y. Identification of miRNA-rich vesicles in bronchoalveolar lavage fluid: insights into the function and heterogeneity of extracellular vesicles. J Control Release. 2019;294:43–52. doi:10.1016/j.jconrel.2018.12.008
   PubMed Web of Science ®Google Scholar
• Zhao G, Jiang K, Yang Y, et al. The potential therapeutic role of miR-223 in bovine endometritis by targeting the NLRP3 inflammasome. Front Immunol. 2018;9:1916. doi:10.3389/fimmu.2018.01916
   PubMed Web of Science ®Google Scholar
• Pachathundikandi SK, Backert S. Helicobacter pylori controls NLRP3 expression by regulating hsa-miR-223-3p and IL-10 in cultured and primary human immune cells. Innate Immun. 2018;24(1):11–23. doi:10.1177/1753425917738043
   PubMed Web of Science ®Google Scholar
• Wang D, Sun S, Xue Y, et al. MicroRNA-223 negatively regulates LPS-induced inflammatory responses by targeting NLRP3 in human dental pulp fibroblasts. Int Endod J. 2021;54(2):241–254. doi:10.1111/iej.13413
   PubMed Web of Science ®Google Scholar
• Liu CC, Miao Y, Chen RL, et al. STIM1 mediates IAV-induced inflammation of lung epithelial cells by regulating NLRP3 and inflammasome activation via targeting miR-223. Life Sci. 2021;266:118845. doi:10.1016/j.lfs.2020.118845
   PubMed Web of Science ®Google Scholar
• Li C, Yin W, Yu N, et al. miR-155 promotes macrophage pyroptosis induced by Porphyromonas gingivalis through regulating the NLRP3 inflammasome. Oral Dis. 2019;25(8):2030–2039. doi:10.1111/odi.13198
   PubMed Web of Science ®Google Scholar
• Deng X, Guo J, Sun Z, et al. Brucella-induced downregulation of lncRNA Gm28309 triggers macrophages inflammatory response through the miR-3068-5p/NF-κB pathway. Front Immunol. 2020;11:581517. doi:10.3389/fimmu.2020.581517
   PubMed Web of Science ®Google Scholar
• Ma M, Pei Y, Wang X, Feng J, Zhang Y, Gao MQ. LncRNA XIST mediates bovine mammary epithelial cell inflammatory response via NF-κB/NLRP3 inflammasome pathway. Cell Prolif. 2019;52(1):e12525. doi:10.1111/cpr.12525
   PubMed Web of Science ®Google Scholar
• Li M, Hua Q, Shao Y, et al. Circular RNA circBbs9 promotes PM(2.5)-induced lung inflammation in mice via NLRP3 inflammasome activation. Environ Int. 2020;143:105976. doi:10.1016/j.envint.2020.105976
   PubMed Web of Science ®Google Scholar
• McVey MJ, Steinberg BE, Goldenberg NM. Inflammasome activation in acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2020. doi:10.1152/ajplung.00303.2020
   PubMedGoogle Scholar
• Feng Z, Qi S, Zhang Y, et al. Ly6G+ neutrophil-derived miR-223 inhibits the NLRP3 inflammasome in mitochondrial DAMP-induced acute lung injury. Cell Death Dis. 2017;8(11):e3170. doi:10.1038/cddis.2017.549
   PubMedGoogle Scholar
• Liao H, Zhang S, Qiao J. Silencing of long non-coding RNA MEG3 alleviates lipopolysaccharide-induced acute lung injury by acting as a molecular sponge of microRNA-7b to modulate NLRP3. Aging. 2020;12(20):20198–20211. doi:10.18632/aging.103752
   PubMedGoogle Scholar
• Cao C, Yin C, Shou S, et al. Ulinastatin protects against LPS-induced acute lung injury by attenuating TLR4/NF-κB pathway activation and reducing inflammatory mediators. Shock. 2018;50(5):595–605. doi:10.1097/shk.0000000000001104
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang F, Yu X, et al. miR-16 inhibits NLRP3 inflammasome activation by directly targeting TLR4 in acute lung injury. Biomed Pharmacother. 2019;112:108664. doi:10.1016/j.biopha.2019.108664
   PubMed Web of Science ®Google Scholar
• Jiao B, Guo S, Yang X, et al. The role of HMGB1 on TDI-induced NLPR3 inflammasome activation via ROS/NF-κB pathway in HBE cells. Int Immunopharmacol. 2021;98:107859. doi:10.1016/j.intimp.2021.107859
   PubMed Web of Science ®Google Scholar
• Lu B, Nakamura T, Inouye K, et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature. 2012;488(7413):670–674. doi:10.1038/nature11290
   PubMed Web of Science ®Google Scholar
• He B, Zhou W, Rui Y, Liu L, Chen B, Su X. MicroRNA-574-5p attenuates acute respiratory distress syndrome by targeting HMGB1. Am J Respir Cell Mol Biol. 2021;64(2):196–207. doi:10.1165/rcmb.2020-0112OC
   PubMed Web of Science ®Google Scholar
• Yan Y, Lu K, Ye T, Zhang Z. MicroRNA‑223 attenuates LPS‑induced inflammation in an acute lung injury model via the NLRP3 inflammasome and TLR4/NF‑κB signaling pathway via RHOB. Int J Mol Med. 2019;43(3):1467–1477. doi:10.3892/ijmm.2019.4075
   PubMed Web of Science ®Google Scholar
• Chen Z, Dong WH, Chen Q, Li QG, Qiu ZM. Downregulation of miR-199a-3p mediated by the CtBP2-HDAC1-FOXP3 transcriptional complex contributes to acute lung injury by targeting NLRP1. Int J Biol Sci. 2019;15(12):2627–2640. doi:10.7150/ijbs.37133
   PubMed Web of Science ®Google Scholar
• Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000;32(4 Pt 1):734–739. doi:10.1053/jhep.2000.17687
   PubMed Web of Science ®Google Scholar
• Antoniades CG, Berry PA, Wendon JA, Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol. 2008;49(5):845–861. doi:10.1016/j.jhep.2008.08.009
   PubMed Web of Science ®Google Scholar
• Jimenez Calvente C, Del Pilar H, Tameda M, Johnson CD, Feldstein AE. MicroRNA 223 3p negatively regulates the NLRP3 inflammasome in acute and chronic liver injury. Mol Ther. 2020;28(2):653–663. doi:10.1016/j.ymthe.2019.09.013
   PubMed Web of Science ®Google Scholar
• Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11(2):136–140. doi:10.1038/ni.1831
   PubMed Web of Science ®Google Scholar
• Biasizzo M, Kopitar-Jerala N. Interplay between NLRP3 inflammasome and autophagy. Front Immunol. 2020;11:591803. doi:10.3389/fimmu.2020.591803
   PubMed Web of Science ®Google Scholar
• Liu JJ, Li Y, Yang MS, Chen R, Cen CQ. SP1-induced ZFAS1 aggravates sepsis-induced cardiac dysfunction via miR-590-3p/NLRP3-mediated autophagy and pyroptosis. Arch Biochem Biophys. 2020;695:108611. doi:10.1016/j.abb.2020.108611
   PubMed Web of Science ®Google Scholar
• Tan J, Fan J, He J, Zhao L, Tang H. Knockdown of LncRNA DLX6-AS1 inhibits HK-2 cell pyroptosis via regulating miR-223-3p/NLRP3 pathway in lipopolysaccharide-induced acute kidney injury. J Bioenerg Biomembr. 2020;52(5):367–376. doi:10.1007/s10863-020-09845-5
   PubMed Web of Science ®Google Scholar
• Zhang X, Huang Z, Wang Y, Wang T, Li J, Xi P. Long non-coding RNA RMRP contributes to sepsis-induced acute kidney injury. Yonsei Med J. 2021;62(3):262–273. doi:10.3349/ymj.2021.62.3.262
   PubMed Web of Science ®Google Scholar
• Zhang C, Gong Y, Li N, et al. Long noncoding RNA Kcnq1ot1 promotes sC5b-9-induced podocyte pyroptosis by inhibiting miR-486a-3p and upregulating NLRP3. Am J Physiol Cell Physiol. 2021;320(3):C355–C364. doi:10.1152/ajpcell.00403.2020
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu MW, Zhao YH, Lu YX, Wang YA, Tong CW. Baicalin attenuates lipopolysaccharide-induced renal tubular epithelial cell injury by inhibiting the TXNIP/NLRP3 signalling pathway via increasing miR-223-3p expression. J Biol Regul Homeost Agents. 2020;34(1):69–82. doi:10.23812/19-502-a
   PubMed Web of Science ®Google Scholar
• Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278(4):369–395. doi:10.1111/joim.12395
   PubMed Web of Science ®Google Scholar
• Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol. 2009;27:621–668. doi:10.1146/annurev.immunol.25.022106.141627
   PubMed Web of Science ®Google Scholar
• Xiao Y, Xu W, Su W. NLRP3 inflammasome: a likely target for the treatment of allergic diseases. Clin Experiment Allergy. 2018;48(9):1080–1091. doi:10.1111/cea.13190
   PubMed Web of Science ®Google Scholar
• Coll RC, Robertson AA, Chae JJ, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21(3):248–255. doi:10.1038/nm.3806
   PubMed Web of Science ®Google Scholar
• Shin JI, Lee KH, Joo YH, et al. Inflammasomes and autoimmune and rheumatic diseases: a comprehensive review. J Autoimmun. 2019;103:102299. doi:10.1016/j.jaut.2019.06.010
   PubMed Web of Science ®Google Scholar
• Iranzo A. Sleep and neurological autoimmune diseases. Neuropsychopharmacology. 2020;45(1):129–140. doi:10.1038/s41386-019-0463-z
   PubMed Web of Science ®Google Scholar
• Shen HH, Yang YX, Meng X, et al. NLRP3: a promising therapeutic target for autoimmune diseases. Autoimmun Rev. 2018;17(7):694–702. doi:10.1016/j.autrev.2018.01.020
   PubMed Web of Science ®Google Scholar
• Neudecker V, Haneklaus M, Jensen O, et al. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. J Exp Med. 2017;214(6):1737–1752. doi:10.1084/jem.20160462
   PubMed Web of Science ®Google Scholar
• Chen L, Hou X, Zhang M, et al. MicroRNA-223-3p modulates dendritic cell function and ameliorates experimental autoimmune myocarditis by targeting the NLRP3 inflammasome. Mol Immunol. 2020;117:73–83. doi:10.1016/j.molimm.2019.10.027
   PubMed Web of Science ®Google Scholar
• Tan W, Gu Z, Leng J, et al. Let-7f-5p ameliorates inflammation by targeting NLRP3 in bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Biomed Pharmacother. 2019;118:109313. doi:10.1016/j.biopha.2019.109313
   PubMed Web of Science ®Google Scholar
• Luo Q, Zeng J, Li W, et al. Silencing of miR‑155 suppresses inflammatory responses in psoriasis through inflammasome NLRP3 regulation. Int J Mol Med. 2018;42(2):1086–1095. doi:10.3892/ijmm.2018.3677
   PubMed Web of Science ®Google Scholar
• Minutoli L, Puzzolo D, Rinaldi M, et al. ROS-mediated NLRP3 inflammasome activation in brain, heart, kidney, and testis ischemia/reperfusion injury. Oxid Med Cell Longev. 2016;2016:2183026. doi:10.1155/2016/2183026
   PubMed Web of Science ®Google Scholar
• Caneparo V, Landolfo S, Gariglio M, De Andrea M. The absent in melanoma 2-like receptor IFN-inducible protein 16 as an inflammasome regulator in systemic lupus erythematosus: the dark side of sensing microbes. Front Immunol. 2018;9:1180. doi:10.3389/fimmu.2018.01180
   PubMed Web of Science ®Google Scholar
• McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97(1):133–144. doi:10.1016/s0092-8674(00)80721-7
   PubMed Web of Science ®Google Scholar
• Krainer J, Siebenhandl S, Weinhäusel A. Systemic autoinflammatory diseases. J Autoimmun. 2020;109:102421. doi:10.1016/j.jaut.2020.102421
   PubMed Web of Science ®Google Scholar
• Jørgensen SE, Christiansen M, Høst C, et al. Systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome due to a CASP1 variant causing inflammasome hyperactivation. Rheumatology. 2020;59(10):3099–3105. doi:10.1093/rheumatology/keaa242
   PubMed Web of Science ®Google Scholar
• Tartey S, Kanneganti TD. Inflammasomes in the pathophysiology of autoinflammatory syndromes. J Leukoc Biol. 2020;107(3):379–391. doi:10.1002/jlb.3mir0919-191r
   PubMed Web of Science ®Google Scholar
• Wada T, Toma T, Matsuda Y, et al. Microarray analysis of circulating microRNAs in familial Mediterranean fever. Mod Rheumatol. 2017;27(6):1040–1046. doi:10.1080/14397595.2017.1285845
   PubMed Web of Science ®Google Scholar
• Akkaya-Ulum YZ, Balci-Peynircioglu B, Karadag O, et al. Alteration of the microRNA expression profile in familial Mediterranean fever patients. Clin Exp Rheumatol. 2017;35(6):90–94.
   PubMed Web of Science ®Google Scholar
• Amarilyo G, Pillar N, Ben-Zvi I, et al. Analysis of microRNAs in familial Mediterranean fever. PLoS One. 2018;13(5):e0197829. doi:10.1371/journal.pone.0197829
   PubMed Web of Science ®Google Scholar
• Hortu HO, Karaca E, Sozeri B, et al. Evaluation of the effects of miRNAs in familial Mediterranean fever. Clin Rheumatol. 2019;38(3):635–643. doi:10.1007/s10067-017-3914-0
   PubMed Web of Science ®Google Scholar
• Akkaya-Ulum YZ, Akbaba TH, Tavukcuoglu Z, et al. Familial Mediterranean fever-related miR-197-3p targets IL1R1 gene and modulates inflammation in monocytes and synovial fibroblasts. Sci Rep. 2021;11(1):685. doi:10.1038/s41598-020-80097-4
   PubMed Web of Science ®Google Scholar
• Herlin T, Jørgensen SE, Høst C, et al. Autoinflammatory disease with corneal and mucosal dyskeratosis caused by a novel NLRP1 variant. Rheumatology. 2020;59(9):2334–2339. doi:10.1093/rheumatology/kez612
   PubMed Web of Science ®Google Scholar
• Canna SW, de Jesus AA, Gouni S, et al. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014;46(10):1140–1146. doi:10.1038/ng.3089
   PubMed Web of Science ®Google Scholar
• Huang Y, Jiang H, Chen Y, et al. Tranilast directly targets NLRP3 to treat inflammasome-driven diseases. EMBO Mol Med. 2018;10(4). doi:10.15252/emmm.201708689
   Web of Science ®Google Scholar
• Cao Y, Zhang H, Lu X, et al. Overexpression of microRNA-9a-5p ameliorates NLRP1 inflammasome-mediated ischemic injury in rats following ischemic stroke. Neuroscience. 2020;444:106–117. doi:10.1016/j.neuroscience.2020.01.008
   PubMed Web of Science ®Google Scholar
• Gu C, Draga D, Zhou C, et al. miR-590-3p inhibits pyroptosis in diabetic retinopathy by targeting NLRP1 and inactivating the NOX4 signaling pathway. Invest Ophthalmol Vis Sci. 2019;60(13):4215–4223. doi:10.1167/iovs.19-27825
   PubMed Web of Science ®Google Scholar
• Malcova H, Milota T, Strizova Z, et al. Interleukin-1 blockade in polygenic autoinflammatory disorders: where are we now? Front Pharmacol. 2020;11:619273. doi:10.3389/fphar.2020.619273
   PubMed Web of Science ®Google Scholar
• Sun J, Feng M, Wu F, et al. Plasma miR-26a as a diagnostic biomarker regulates cytokine expression in systemic juvenile idiopathic arthritis. J Rheumatol. 2016;43(8):1607–1614. doi:10.3899/jrheum.150593
   PubMed Web of Science ®Google Scholar
• Li D, Duan M, Feng Y, Geng L, Li X, Zhang W. MiR-146a modulates macrophage polarization in systemic juvenile idiopathic arthritis by targeting INHBA. Mol Immunol. 2016;77:205–212. doi:10.1016/j.molimm.2016.08.007
   PubMed Web of Science ®Google Scholar
• Do T, Tan R, Bennett M, et al. MicroRNA networks associated with active systemic juvenile idiopathic arthritis regulate CD163 expression and anti-inflammatory functions in macrophages through two distinct mechanisms. J Leukoc Biol. 2018;103(1):71–85. doi:10.1002/jlb.2a0317-107r
   PubMed Web of Science ®Google Scholar
• Sebastião AI, Ferreira I, Brites G, Silva A, Neves BM, Teresa Cruz M. NLRP3 inflammasome and allergic contact dermatitis: a connection to demystify. Pharmaceutics. 2020;12(9):867. doi:10.3390/pharmaceutics12090867
   PubMed Web of Science ®Google Scholar
• Tan HT, Hagner S, Ruchti F, et al. Tight junction, mucin, and inflammasome-related molecules are differentially expressed in eosinophilic, mixed, and neutrophilic experimental asthma in mice. Allergy. 2019;74(2):294–307. doi:10.1111/all.13619
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen S, Yang PL, Chen JJ, Kong WJ, Wang YJ. AIM2 inflammasome activation may mediate high mobility group box 1 release in murine allergic rhinitis. Braz J Otorhinolaryngol. 2021. doi:10.1016/j.bjorl.2020.12.014
   Web of Science ®Google Scholar
• Dombrowski Y, Peric M, Koglin S, et al. Honey bee (Apis mellifera) venom induces AIM2 inflammasome activation in human keratinocytes. Allergy. 2012;67(11):1400–1407. doi:10.1111/all.12022
   PubMed Web of Science ®Google Scholar
• Yu X, Wang M, Zhao H, Cao Z. Targeting a novel hsa_circ_0000520/miR-556-5p/NLRP3 pathway-mediated cell pyroptosis and inflammation attenuates ovalbumin (OVA)-induced allergic rhinitis (AR) in mice models. Inflam Res. 2021;70(6):719–729. doi:10.1007/s00011-021-01472-z
   PubMed Web of Science ®Google Scholar
• Wu J, Wu L, Zhang L, et al. Overexpression of miR-224-5p alleviates allergic rhinitis in mice via the TLR4/MyD88/NF-κB pathway. Experiment Anim. 2021. doi:10.1538/expanim.20-0195
   Web of Science ®Google Scholar
• Xiao L, Jiang L, Hu Q, Li Y. MicroRNA-133b ameliorates allergic inflammation and symptom in murine model of allergic rhinitis by targeting Nlrp3. Cell Physiol Biochem. 2017;42(3):901–912. doi:10.1159/000478645
   PubMedGoogle Scholar
• Khoury HJ, Wang T, Hemmer MT, et al. Improved survival after acute graft-versus-host disease diagnosis in the modern era. Haematologica. 2017;102(5):958–966. doi:10.3324/haematol.2016.156356
   PubMed Web of Science ®Google Scholar
• Zhang M, Zheng Y, Sun Y, et al. Knockdown of NEAT1 induces tolerogenic phenotype in dendritic cells by inhibiting activation of NLRP3 inflammasome. Theranostics. 2019;9(12):3425–3442. doi:10.7150/thno.33178
   PubMed Web of Science ®Google Scholar
• Jankovic D, Ganesan J, Bscheider M, et al. The Nlrp3 inflammasome regulates acute graft-versus-host disease. J Exp Med. 2013;210(10):1899–1910. doi:10.1084/jem.20130084
   PubMed Web of Science ®Google Scholar
• Zeiser R, Penack O, Holler E, Idzko M. Danger signals activating innate immunity in graft-versus-host disease. J Mol Med. 2011;89(9):833–845. doi:10.1007/s00109-011-0767-x
   PubMed Web of Science ®Google Scholar
• Chen S, Smith BA, Iype J, et al. MicroRNA-155-deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation. Blood. 2015;126(1):103–112. doi:10.1182/blood-2014-12-617258
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhao Y, Wu G, Lin B, Li Z, Liu X. Differential miRNAomics of the synovial membrane in knee osteoarthritis induced by bilateral anterior cruciate ligament transection in rats. Mol Med Rep. 2018;18(4):4051–4057. doi:10.3892/mmr.2018.9385
   PubMed Web of Science ®Google Scholar
• Dong HC, Li PN, Chen CJ, et al. Sinomenine attenuates cartilage degeneration by regulating miR-223-3p/NLRP3 inflammasome signaling. Inflammation. 2019;42(4):1265–1275. doi:10.1007/s10753-019-00986-3
   PubMed Web of Science ®Google Scholar
• Wang B, Li J, Tian F. Downregulation of lncRNA SNHG14 attenuates osteoarthritis by inhibiting FSTL-1 mediated NLRP3 and TLR4/NF-κB pathway through miR-124-3p. Life Sci. 2021;270:119143. doi:10.1016/j.lfs.2021.119143
   PubMed Web of Science ®Google Scholar
• Xu J, Pei Y, Lu J, et al. LncRNA SNHG7 alleviates IL-1β-induced osteoarthritis by inhibiting miR-214-5p-mediated PPARGC1B signaling pathways. Int Immunopharmacol. 2021;90:107150. doi:10.1016/j.intimp.2020.107150
   PubMed Web of Science ®Google Scholar
• Alegre F, Pelegrin P, Feldstein AE. Inflammasomes in liver fibrosis. Semin Liver Dis. 2017;37(2):119–127. doi:10.1055/s-0037-1601350
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang Z. Effect and regulation of the NLRP3 inflammasome during renal fibrosis. Front Cell Dev Biol. 2019;7:379. doi:10.3389/fcell.2019.00379
   PubMed Web of Science ®Google Scholar
• Ling M, Li Y, Xu Y, et al. Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-κB in arsenite-induced cell transformation. Free Radic Biol Med. 2012;52(9):1508–1518. doi:10.1016/j.freeradbiomed.2012.02.020
   PubMed Web of Science ®Google Scholar
• Ning ZW, Luo XY, Wang GZ, et al. MicroRNA-21 mediates angiotensin II-induced liver fibrosis by activating NLRP3 inflammasome/IL-1β axis via targeting Smad7 and Spry1. Antioxid Redox Signal. 2017;27(1):1–20. doi:10.1089/ars.2016.6669
   PubMed Web of Science ®Google Scholar
• Zhang K, Shi Z, Zhang M, et al. Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis. Cell Death Dis. 2020;11(2):132. doi:10.1038/s41419-020-2323-5
   PubMed Web of Science ®Google Scholar
• Zhang T, Hu J, Wang X, et al. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway. J Hepatol. 2019;70(1):87–96. doi:10.1016/j.jhep.2018.08.026
   PubMed Web of Science ®Google Scholar
• Calvente CJ, Tameda M, Johnson CD, et al. Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223. J Clin Invest. 2019;129(10):4091–4109. doi:10.1172/jci122258
   PubMed Web of Science ®Google Scholar
• Chen X, Li HD, Bu FT, et al. Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis. Theranostics. 2020;10(11):4851–4870. doi:10.7150/thno.42423
   PubMed Web of Science ®Google Scholar
• Bala S, Csak T, Saha B, et al. The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis. J Hepatol. 2016;64(6):1378–1387. doi:10.1016/j.jhep.2016.01.035
   PubMed Web of Science ®Google Scholar
• Sun NN, Yu CH, Pan MX, et al. Mir-21 mediates the inhibitory effect of Ang (1-7) on AngII-induced NLRP3 inflammasome activation by targeting Spry1 in lung fibroblasts. Sci Rep. 2017;7(1):14369. doi:10.1038/s41598-017-13305-3
   PubMedGoogle Scholar
• Zou XZ, Gong ZC, Liu T, et al. Involvement of epithelial-mesenchymal transition afforded by activation of LOX-1/ TGF-β1/KLF6 signaling pathway in diabetic pulmonary fibrosis. Pulm Pharmacol Ther. 2017;44:70–77. doi:10.1016/j.pupt.2017.03.012
   PubMed Web of Science ®Google Scholar
• Sun L, Zhu M, Feng W, et al. Exosomal miRNA Let-7 from menstrual blood-derived endometrial stem cells alleviates pulmonary fibrosis through regulating mitochondrial DNA damage. Oxid Med Cell Longev. 2019;2019:4506303. doi:10.1155/2019/4506303
   PubMed Web of Science ®Google Scholar
• Li X, Du N, Zhang Q, et al. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death Dis. 2014;5(10):e1479. doi:10.1038/cddis.2014.430
   PubMedGoogle Scholar
• Chen A, Chen Z, Xia Y, et al. Liraglutide attenuates NLRP3 inflammasome-dependent pyroptosis via regulating SIRT1/NOX4/ROS pathway in H9c2 cells. Biochem Biophys Res Commun. 2018;499(2):267–272. doi:10.1016/j.bbrc.2018.03.142
   PubMed Web of Science ®Google Scholar
• Mao Q, Liang XL, Zhang CL, Pang YH, Lu YX. LncRNA KLF3-AS1 in human mesenchymal stem cell-derived exosomes ameliorates pyroptosis of cardiomyocytes and myocardial infarction through miR-138-5p/Sirt1 axis. Stem Cell Res Ther. 2019;10(1):393. doi:10.1186/s13287-019-1522-4
   PubMed Web of Science ®Google Scholar
• Li F, Zhang L, Xue H, Xuan J, Rong S, Wang K. SIRT1 alleviates hepatic ischemia-reperfusion injury via the miR-182-mediated XBP1/NLRP3 pathway. Mol Ther Nucleic Acids. 2021;23:1066–1077. doi:10.1016/j.omtn.2020.11.015
   PubMedGoogle Scholar
• Liang J, Wang Q, Li JQ, Guo T, Yu D. Long non-coding RNA MEG3 promotes cerebral ischemia-reperfusion injury through increasing pyroptosis by targeting miR-485/AIM2 axis. Exp Neurol. 2020;325:113139. doi:10.1016/j.expneurol.2019.113139
   PubMed Web of Science ®Google Scholar
• Cheng J, Liu Q, Hu N, et al. Downregulation of hsa_circ_0068087 ameliorates TLR4/NF-κB/NLRP3 inflammasome-mediated inflammation and endothelial cell dysfunction in high glucose conditioned by sponging miR-197. Gene. 2019;709:1–7. doi:10.1016/j.gene.2019.05.012
   PubMed Web of Science ®Google Scholar
• Han Y, Xu X, Tang C, et al. Reactive oxygen species promote tubular injury in diabetic nephropathy: the role of the mitochondrial ros-txnip-nlrp3 biological axis. Redox Biol. 2018;16:32–46. doi:10.1016/j.redox.2018.02.013
   PubMed Web of Science ®Google Scholar
• Yu J, Nagasu H, Murakami T, et al. Inflammasome activation leads to Caspase-1-dependent mitochondrial damage and block of mitophagy. Proc Natl Acad Sci U S A. 2014;111(43):15514–15519. doi:10.1073/pnas.1414859111
   PubMed Web of Science ®Google Scholar
• Shi Z, Zhang K, Zhou H, et al. Increased miR-34c mediates synaptic deficits by targeting synaptotagmin 1 through ROS-JNK-p53 pathway in Alzheimer’s disease. Aging Cell. 2020;19(3):e13125. doi:10.1111/acel.13125
   PubMed Web of Science ®Google Scholar
• Lin YH. MicroRNA networks modulate oxidative stress in cancer. Int J Mol Sci. 2019;20(18):4497. doi:10.3390/ijms20184497
   PubMed Web of Science ®Google Scholar
• Zhao XJ, Yu HW, Yang YZ, et al. Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway. Redox Biol. 2018;18:124–137. doi:10.1016/j.redox.2018.07.002
   PubMed Web of Science ®Google Scholar
• Liu J, Yao L, Zhang M, Jiang J, Yang M, Wang Y. Downregulation of LncRNA-XIST inhibited development of non-small cell lung cancer by activating miR-335/SOD2/ROS signal pathway mediated pyroptotic cell death. Aging. 2019;11(18):7830–7846. doi:10.18632/aging.102291
   PubMedGoogle Scholar
• Crane DD, Bauler TJ, Wehrly TD, Bosio CM. Mitochondrial ROS potentiates indirect activation of the AIM2 inflammasome. Front Microbiol. 2014;5:438. doi:10.3389/fmicb.2014.00438
   PubMed Web of Science ®Google Scholar
• Xu T, Sun L, Shen X, et al. NADPH oxidase 2-mediated NLRP1 inflammasome activation involves in neuronal senescence in hippocampal neurons in vitro. Int Immunopharmacol. 2019;69:60–70. doi:10.1016/j.intimp.2019.01.025
   PubMed Web of Science ®Google Scholar
• Matsui M, Corey DR. Non-coding RNAs as drug targets. Nat Rev Drug Discov. 2017;16(3):167–179. doi:10.1038/nrd.2016.117
   PubMed Web of Science ®Google Scholar
• Chen X, Yang T, Wang W, et al. Circular RNAs in immune responses and immune diseases. Theranostics. 2019;9(2):588–607. doi:10.7150/thno.29678
   PubMed Web of Science ®Google Scholar
• Piwecka M, Glažar P, Hernandez-Miranda LR, et al. Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science. 2017;357:6357. doi:10.1126/science.aam8526
   Web of Science ®Google Scholar